Opin vísindi

In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden

In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden


Title: In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden
Author: Agustsson, Arnar S.
Birgisson, Helgi
Agnarsson, Bjarni A.
Jonsson, Thorvaldur
Stefansdottir, Hrefna
Wärnberg, Fredrik
Lambe, Mats
Tryggvadottir, Laufey   orcid.org/0000-0001-8067-9030
Sverrisdottir, Asgerdur
Date: 2020-12-01
Language: English
Scope:
Department: Perioperative Services
Faculty of Medicine
Clinical Laboratory Services, Diagnostics and Blood Bank
Series: Scientific Reports; 10(1)
ISSN: 2045-2322
DOI: https://doi.org/10.1038/s41598-020-74134-5
Subject: Multidisciplinary
URI: https://hdl.handle.net/20.500.11815/3431

Show full item record

Citation:

Agustsson , A S , Birgisson , H , Agnarsson , B A , Jonsson , T , Stefansdottir , H , Wärnberg , F , Lambe , M , Tryggvadottir , L & Sverrisdottir , A 2020 , ' In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden ' , Scientific Reports , vol. 10 , no. 1 , 17623 . https://doi.org/10.1038/s41598-020-74134-5

Abstract:

The purpose was to review the incidence of in situ carcinoma in Iceland after initiating population-based mammography screening in 1987 and to compare management of ductal carcinoma in situ (DCIS) between Iceland and the Uppsala–Örebro region (UÖR) in Central Sweden. The Icelandic Cancer Registry provided data on in situ breast carcinomas for women between 1957 and 2017. Clinical data for women with DCIS between 2008 and 2014 was extracted from hospital records and compared to women diagnosed in UÖR. In Iceland, in situ carcinoma incidence increased from 7 to 30 per 100 000 women per year, following the introduction of organised mammography screening. The proportion of in situ carcinoma of all breast carcinomas increased from 4 to 12%. More than one third (35%) of women diagnosed with DCIS in Iceland were older than 70 years versus 18% in UÖR. In Iceland, 49% of all DCIS women underwent mastectomy compared to 40% in UÖR. The incidence of in situ carcinoma in Iceland increased four-fold after the uptake of population-based mammography screening causing considerable risk of overtreatment. Differences in treatment of DCIS were seen between Iceland and UÖR, revealing the importance of quality registration for monitoring patterns of management.

Description:

Funding We thank the Icelandic Cancer Society, the Icelandic Oncologists Research fund and Göngum Saman, a nonprofit organization, for financial support. Publisher Copyright: © 2020, The Author(s).

Files in this item

This item appears in the following Collection(s)